SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-213059
Filing Date
2020-08-07
Accepted
2020-08-07 16:25:54
Documents
4
Effectiveness Date
2020-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 d14794ds8.htm S-8 69844
2 EX-5.1 d14794dex51.htm EX-5.1 4572
3 EX-23.1 d14794dex231.htm EX-23.1 1778
4 GRAPHIC g14794g27e62.jpg GRAPHIC 2608
  Complete submission text file 0001193125-20-213059.txt   80931
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-242336 | Film No.: 201085361
SIC: 2834 Pharmaceutical Preparations